{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-043558","form_type":"8-K","ticker":"IBO","cik":"0001834105","company_name":"IMPACT BIOMEDICAL INC.","filed_at":"2024-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.919232+00:00","generated_at":"2026-05-30T06:17:06.137865+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Impact Biomedical furnishes investor presentation; no specific financial updates disclosed","bullets":["COO Mark Suseck began delivering investor presentations on November 4, 2024.","Presentation slide deck furnished as Exhibit 99.1; no new financial data or guidance in the filing.","Company does not assume obligation to update the presentation information.","No material operational metrics, revenue, or earnings figures provided in the 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-043558","json":"https://secwatch.observer/filing/0001493152-24-043558.json","markdown":"https://secwatch.observer/filing/0001493152-24-043558.md","text":"https://secwatch.observer/filing/0001493152-24-043558.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834105/000149315224043558/0001493152-24-043558-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834105/000149315224043558/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T06:17:06.137865+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}